Kyle Rose
Stock Analyst at Canaccord Genuity
(2.61)
# 2,078
Out of 5,152 analysts
112
Total ratings
51.61%
Success rate
13.12%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $240.94 | +86.77% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $34.85 | -22.53% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $370.50 | +17.41% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $89.29 | -20.48% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $24.32 | +191.94% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $13.45 | +63.57% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.13 | +784.96% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $12.57 | +75.02% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $70.69 | +112.19% | 17 | Jul 28, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $14.07 | +91.90% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.85 | +1,671.17% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $29.16 | -48.56% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $164.00 | -25.61% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.66 | -14.07% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.10 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $93.45 | +33.76% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $240.94
Upside: +86.77%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $34.85
Upside: -22.53%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $370.50
Upside: +17.41%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $89.29
Upside: -20.48%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $24.32
Upside: +191.94%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $13.45
Upside: +63.57%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.13
Upside: +784.96%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $12.57
Upside: +75.02%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $70.69
Upside: +112.19%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $14.07
Upside: +91.90%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.85
Upside: +1,671.17%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $29.16
Upside: -48.56%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $164.00
Upside: -25.61%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.66
Upside: -14.07%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $9.10
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $93.45
Upside: +33.76%